Wim A. van der Steeg, M.D.; Christopher P. Cannon, M.D., F.A.C.C. As extensively discussed in literature, this unexpected outcome is hypothesized to relate to the ...

New research has found that women who have had both ovaries surgically removed before the age of 50 and carry a variant of the apolipoprotein gene, the APOE4 allele, are at high risk of late-life ...

Dose-dependent reductions in apolipoprotein B were seen for 8.9, 13.1, and 16.1 percent at doses of 10, 60, and 240 mg/day, ...

As with other disease states, biomarkers that can provide value across diagnosis, prognosis, and treatment response, have ...

TORONTO: Women who have had both ovaries surgically removed before age 50, and carry a variant of the apolipoprotein gene, ...

Women who have had both ovaries surgically removed before age 50, and carry a variant of the apolipoprotein gene, are at a ...

2 Department of Movement Sciences, Maastricht University, Maastricht, the Netherlands 3 Department of Endocrinology, University Hospital Groningen, Groningen, the Netherlands Correspondence to: Dr ...

Plozasiran, at the 25 mg dose being proposed for marketing approval, induced rapid, deep, and sustained reductions in apolipoprotein C-III, of greater than 90%, and in triglycerides, of approximately ...